(redirected from Macrophage migration inhibitory factor)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.
Related to Macrophage migration inhibitory factor: PubMed


This article is provided by FOLDOC - Free Online Dictionary of Computing (foldoc.org)


(1) (Maker Interchange Format) An alternate file format for a FrameMaker document. A MIF file is ASCII text, which can be created in another program and imported into FrameMaker.

(2) (Management Information File) A DMI file format that describes a hardware or software component used in a PC. It can contain data, code or both. See DMI.

(3) (Machine Interface Format) A proprietary language for configuring Ascend networking devices. Instead of setting up via menus one option at a time, a MIF file can be created with all the changes and uploaded to the unit.

(4) (Multiple Image Facility) The management of ESCON and FICON mainframe channels so that multiple LPARs (Logical PARtitions) may share it concurrently. See ESCON, FICON and LPAR.
Copyright © 1981-2019 by The Computer Language Company Inc. All Rights reserved. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction is strictly prohibited without permission from the publisher.
References in periodicals archive ?
Schmid et al., "High plasma levels of gremlin-1 and macrophage migration inhibitory factor, but not their ratio, indicate an increased risk for acute coronary syndrome in patients with type 2 diabetes mellitus," Clinical Cardiology, vol.
Koenig et al., "Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the cooperative health research in the region of Augsburg, survey 4 (KORA S4)," Diabetes Care, vol.
Carskadon et al., "Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis," Clinical Cancer Research, vol.
Global Markets Direct's, 'Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC - Pipeline Review, H1 2016', provides in depth analysis on Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC targeted pipeline therapeutics.
Hyperglycemia is a causal factor for increased levels of macrophage migration inhibitory factor which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes.
Macrophage migration inhibitory factor (MIF) is a chemokine that prevents the random migration of macrophages, stimulates their recruitment at sites of inflammation, and increases their adherence, motility, and phagocytosis [71].
Macrophage migration inhibitory factor and its relationship with obesity and diabetes.
(11.) Rahman SH, Menon KV, Holmfield JH, McMahon MJ, Guillou JP: Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Macrophage migration inhibitory factor (MIF) activates macrophages and may therefore play a role in retaining these cells into the inflammatory sites [45].
The researchers whittled the field of potential biomarkers down to eight: prolactin, transthyretin, thrombospondin-1, E-selectin, C-C motif chemokine 5, macrophage migration inhibitory factor, plasminogen activator inhibitor 1, and receptor tyrosine-protein kinase erbB-2.
Macrophage migration inhibitory factor (MIF) is a cytokine produced by lymphocytes and peripheral blood mononuclear cells.
A number of adipokines, including leptin, adiponectin, tumour necrosis factor alpha, IL-1beta (interleukin 1beta), IL-6, monocyte chemotactic protein-1, macrophage migration inhibitory factor, nerve growth factor, vascular endothelial growth factor, plasminogen activator inhibitor 1 and haptoglobin, are linked to inflammation and the inflammatory response.

Full browser ?